Roles of two subtypes of corticotrophin-releasing factor receptor in the corticostriatal long-term potentiation under cocaine withdrawal condition

Journal of Neurochemistry

Volumn 115, Issue 3, 2010, Pages 795-803

  Guan, Xiaowei ^a   Wang, Lina ^a   Chen, Chun Lin ^b   Guan, Yun ^b   Li, Shengnan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Corticostriatal; Corticotrophin releasing factor receptors; Corticotrophin releasing factor related peptides; Long term potentiation

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ASTRESSION 2B; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UROCORTIN II;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN SLICE; COCAINE DEPENDENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DETOXIFICATION; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; MEMBRANE STEADY POTENTIAL; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RELAPSE;

ANIMALS; CEREBRAL CORTEX; COCAINE; CORPUS STRIATUM; CORTICOTROPIN-RELEASING HORMONE; ELECTROPHYSIOLOGY; LONG-TERM POTENTIATION; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPSES; UROCORTINS; VENTRAL TEGMENTAL AREA;

RATTUS;

EID: 78651273608     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06981.x     Document Type: Article

References (68)

1. Abuirmeileh A., Harkavyi A., Kingsbury A., Lever R. and Whitton P. S. (2009) The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors. Eur. J. Pharmacol. 604, 45-50.
2. Anker J. J. and Carroll M. E. (2010) Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats. Psychopharmacology 208, 211-222.
3. Autelitano D. J. and Cohen D. R. (1996) CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol. Cell. Endocrinol. 119, 25-35.
4. Bonci A. and Borgland S. (2009) Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 56, 107-111.
5. Calabresi P., Picconi B., Tozzi A. and Di Filippo M. (2007) Dopaminemediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30, 211-219.
6. Centonze D., Costa C., Rossi S., Prosperetti C., Pisani A., Usiello A., Bernardi G., Mercuri N. B. and Calabresi P. (2006) Chronic cocaine prevents depotentiation at corticostriatal synapses. Biol. Psychiatry 60, 436-443.
7. Challis J. R. and Brooks A. N. (1989) Maturation and activation of hypothalamic-pituitary adrenal function in fetal sheep. Endocr. Rev. 10, 182-204.
8. Chen A. M., Perrin M. H., Digruccio M. R., Vaughan J. M., Brar B. K., Arias C. M., Lewis K. A., Rivier J. E., Sawchenko P. E. and Vale W. W. (2005) A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl Acad. Sci. USA 102, 2620-2625.
9. Contarino A., Heinrichs S. C and Gold L. H. (1999) Understanding corticotropin releasing factor neurobiology: Contributions from mutant mice. Neuropeptides 33, 1-12.
10. Corominas M., Roncero C. and Casas M. (2010) Corticotropin releasing factor and neuroplasticity in cocaine addiction. Life Sci. 86, 1-9.
11. Everitt B. J. and Robbins T. W. (2005) Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489.
12. Francesconi W., Berton F., Repunte-Canonigo V. et al. (2009) Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J. Neurosci. 29, 5389-5401.
13. Fu Y. and Neugebauer V. (2008) Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J. Neurosci. 28, 3861-3876.
14. Fu Y., Pollandt S., Liu J., Krishnan B., Genzer K., Orozco-Cabal L., Gallagher J. P. and Shinnick-Gallagher P. (2007) Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. J. Neurophysiol. 97, 937-941.
15. Funk C. K., Zorrilla E. P., Lee M. J., Rice K. C. and Koob G. F. (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61, 78-86.
16. Gallagher J. P., Orozco-Cabal L. F., Liu J. and Shinnick-Gallagher P. (2008) Synaptic physiology of central CRH system. Eur. J. Pharmacol. 583, 215-225.
17. Gerdeman G. L., Partridge J. G., Lupica C. R. and Lovinger D. M. (2003) It could be habit forming: Drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26, 184-192.
18. Gottowik J., Goetschy V., Henriot S., Kitas E., Fluhman B., Clerc R. G., Moreau J. L., Monsma F. J. and Kilpatrick G. J. (1997) Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]- urocortin. Neuropharmacology 36, 1439-1446.
19. Guan X., Zhang R., Xu Y. and Li S. (2009) Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of corticotropin-releasing factor receptor subtype 2. Neuroscience 161, 665-670.
20. Gurkovskaya O. and Goeders N. E. (2001) Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Eur. J. Pharmacol. 432, 53-56.
21. Hahn J., Hopf F. W. and Bonci A. (2009) Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J. Neurosci. 29, 6535-6544.
22. Hauger R. L., Risbrough V., Oakley R. H., Olivares-Reyes J. A. and Dautzenberg F. M. (2009) Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. NY Acad. Sci. 1179, 120-143.
23. Hyman S. E. (2005) Addiction: A disease of learning and memory. Am. J. Psychiatry 162, 1414-1422.
24. Isogawa K., Akiyoshi J., Hikichi T., Yamamoto Y., Tsutsumi T. and Nagayama H. (2000) Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo. Neuropeptides 34, 234-239.
25. Ji G. and Neugebauer V. (2007) Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J. Neurophysiol. 97, 3893-3904.
26. Kageyama K., Hanada K., Moriyama T., Imaizumi T., Satoh K. and Suda T. (2007) Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol. Cell. Endocrinol. 263, 90-102.
27. Kalivas P. W. (2008) Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox. Res. 14, 185-189.
28. Kalivas P. W. and McFarland K. (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 168, 44-56.
29. Kash T. L., Nobis W. P., Matthews R. T. and Winder D. G. (2008) Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J. Neurosci. 28, 13856-13865.
30. Koob G. F. (2010) The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 1314, 3-14.
31. Koob G. F. and Heinrichs S. C. (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848, 141-152.
32. Koob G. F. and Zorrilla E. P. (2010) Neurobiological mechanisms of addiction: Focus on corticotropin-releasing factor. Curr. Opin. Investig. Drugs 11, 63-71.
33. Korosi A., Veening J. G., Kozicz T., Henckens M., Dederen J., Groenink L., van der Gugten J., Olivier B. and Roubos E. W. (2006) Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res. 1072, 46-54.
34. Krishnan B., Centeno M., Pollandt S., Fu Y., Genzer K., Liu J., Gallagher J. P. and Shinnick-Gallagher P. (2010) Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced longterm potentiation in the rat amygdala following cocaine withdrawal. Eur. J. Neurosci. 31, 1027-1042.
35. Lawrence A. J., Parish C. L., Chen F., Lodge D. J., Krstew E. V., Card K., Finkelstein D. I. and Horne M. K. (2005) Chronic corticotropin- releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats. J. Neurochem. 94, 1523-1534.
36. Liu J., Yu B., Orozco-Cabal L., Grigoriadis D. E., Rivier J., Vale W. W., Shinnick-Gallagher P. and Gallagher J. P. (2005) Chronic cocaine administration switches corticotropin-releasing factor2 receptormediated depression to facilitation of glutamatergic transmission in the lateral septum. J. Neurosci. 25, 577-583.
37. Lovejoy D. A. and Balment R. J. (1999) Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen. Comp. Endocrinol. 115, 1-22.
38. Lovinger D. M., Partridge J. G. and Tang K. C. (2003) Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse. Ann. NY Acad. Sci. 1003, 226-240.
39. Lu L., Liu D. and Ceng X. (2001) Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur. J. Pharmacol. 415, 203-208.
40. Lu L., Liu Z., Huang M. and Zhang Z. (2003) Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J. Neurochem. 84, 1378-1386.
41. Ma Y. L., Chen K. Y., Wei C. L. and Lee E. H. (1999) Corticotropinreleasing factor enhances brain-derived neurotrophic factor gene expression to facilitate memory retention in rats. Chin. J. Physiol. 42, 73-81.
42. Mameli M., Halbout B., Creton C., Engblom D., Parkitna J. R., Spanagel R. and Lscher C. (2009) Cocaine-evoked synaptic plasticity: Persistence in the VTA triggers adaptations in the NAc. Nat. Neurosci. 12, 1036-1041.
43. McMahon R. C. (2001) Personality, stress, and social support in cocaine relapse prediction. J. Subst. Abuse Treat. 21, 77-87.
44. Nakajima A., Yamada K., He J., Zeng N., Nitta A. and Nabeshima T. (2004) Anatomical substrates for the discriminative stimulus effects of methamphetamine in rats. J. Neurochem. 91, 308-317.
45. Orozco-Cabal L., Pollandt S., Liu J., Shinnick-Gallagher P. and Gallagher J. P. (2006) Regulation of synaptic transmission by CRF receptors. Rev. Neurosci. 17, 279-307.
46. Orozco-Cabal L., Liu J., Pollandt S., Schmidt K., Shinnick-Gallagher P. and Gallagher J. P. (2008) Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: Functional switch after chronic cocaine administration. J. Neurosci. 28, 529-542.
47. Papaleo F., Ghozland S., Ingallinesi M., Roberts A. J., Koob G. F. and Contarino A. (2008) Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 33, 2878-2887.
48. Perrin M. H. and Vale W. W. (1999) Corticotropin releasing factor receptors and their ligand family. Ann. N Y Acad. Sci. 885, 312-328.
49. Perrin M. H., Donaldson C. J., Chen R., Lewis K. A. and Vale W. W. (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133, 3058-3061.
50. Pollandt S., Liu J., Orozco-Cabal L., Grigoriadis D. E., Vale W. W., Gallagher J. P. and Shinnick-Gallagher P. (2006) Cocaine withdrawal enhances long-term potentiation induced by corticotropinreleasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur. J. Neurosci. 24, 1733-1743.
51. Rebaudo R., Melani R., Balestrino M. and Izvarina N. (2001) Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res. 922, 112-117.
52. Risbrough V. B., Hauger R. L., Roberts A. L., Vale W. W. and Geyer M. A. (2004) Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 24, 6545-6552.
53. Rueda-Orozco P. E., Mendoza E., Hernandez R., Aceves J. J., Ibanez- Sandoval O., Galarraga E. and Bargas J. (2009) Diversity in long-term synaptic plasticity at inhibitory synapses of striatal spiny neurons. Learn Mem. 16, 474-478.
54. Sarnyai Z., Shaham Y. and Heinrichs S. C. (2001) The role of corticotropin- releasing factor in drug addiction. Pharmacol. Rev. 53, 209-243.
55. Skelton K. H., Nemeroff C. B. and Owens M. J. (2004) Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. J. Neurosci. 24, 9303-9312.
56. Suda T., Kageyama K., Sakihara S. and Nigawara T. (2004) Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors. Peptides 25, 1689-1701.
57. Tagliaferro P. and Morales M. (2008) Synapses between corticotropinreleasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J. Comp. Neurol. 506, 616-626.
58. Thomas M. J., Kalivas P. W. and Shaham Y. (2008) Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 154, 327-342.
59. Valdez G. R., Sabino V. and Koob G. F. (2004) Increased anxiety-like behavior and ethanol self-administration in dependent rats: Reversal via corticotropin-releasing factor-2 receptor activation. Alcohol. Clin. Exp. Res. 28, 865-872.
60. Van den Oever M. C., Goriounova N. A., Li K. W. et al. (2008) Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat. Neurosci. 11, 1053-1058.
61. Van Pett K., Viau V., Bittencourt J. C., Chan R. K., Li H. Y., Arias C., Prins G. S., Perrin M., Vale W. and Sawchenko P. E. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428, 191-212.
62. Vuong S. M., Oliver H. A., Scholl J. L., Oliver K. M. and Forster G. L. (2010) Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav. Brain Res. 208, 278-281.
63. Wanat M. J., Hopf F.W., Stuber G. D., Phillips P. E. and Bonci A. (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J. Physiol. 586, 2157-2170.
64. Wang H. L. and Morales M. (2008) Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J. Comp. Neurol. 509, 302-318.
65. Wang B., Shaham Y., Zitzman D., Azari S., Wise R. A. and You Z. B. (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: A role in stress-induced relapse to drug seeking. J. Neurosci. 25, 5389-5396.
66. Wang B., You Z. B., Rice K. C. and Wise R. A. (2007) Stress-induced relapse to cocaine seeking: Roles for the CRF(2) receptor and CRFbinding protein in the ventral tegmental area of the rat. Psychopharmacology 193, 283-294.
67. Wise R. A. and Morales M. (2010) A ventral tegmental CRF- glutamatedopamine interaction in addiction. Brain Res. 1314, 38-43.
68. Yuan P. Q., Million M., Wu S. V., Rivier J. and Tache Y. (2007) Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol. Motil. 19, 923-936.